Many of our other senolytics are repurposed cancer drugs at lower dosages. This one apparently has very high efficacy near 100%. Time and continued study will tell us if this will have the right safety profile. Looks promising.
FDA Accelerates Blinatumomab for performance in Leukemia, Could it be a good senolytic?
Started by
YOLF
, Apr 07 2018 12:47 PM
senolytics
1 reply to this topic
Also tagged with one or more of these keywords: senolytics
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users